Literature DB >> 25314079

Acetylation of snail modulates the cytokinome of cancer cells to enhance the recruitment of macrophages.

Dennis Shin-Shian Hsu1, Hsiao-Jung Wang1, Shyh-Kuan Tai2, Chun-Hung Chou1, Chia-Hsin Hsieh3, Po-Hsien Chiu1, Nien-Jung Chen4, Muh-Hwa Yang5.   

Abstract

Snail is primarily known as a transcriptional repressor that induces epithelial-mesenchymal transition by suppressing adherent proteins. Emerging evidence suggests that Snail can act as an activator; however, the mechanism and biological significance are unclear. Here, we found that CREB-binding protein (CBP) is the critical factor in Snail-mediated target gene transactivation. CBP interacts with Snail and acetylates Snail at lysine 146 and lysine 187, which prevents the repressor complex formation. We further identified several Snail-activated targets, including TNF-α, which is also the upstream signal for Snail acetylation, and CCL2 and CCL5, which promote the recruitment of tumor-associated macrophages. Here, we present our results on the mechanism by which Snail induces target gene transactivation to remodel the tumor microenvironment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25314079     DOI: 10.1016/j.ccell.2014.09.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

Review 1.  Tumor-derived exosomes in the regulation of macrophage polarization.

Authors:  Mirza S Baig; Anjali Roy; Sajjan Rajpoot; Dongfang Liu; Rajkumar Savai; Sreeparna Banerjee; Manabu Kawada; Syed M Faisal; Rohit Saluja; Uzma Saqib; Tomokazu Ohishi; Kishore K Wary
Journal:  Inflamm Res       Date:  2020-03-11       Impact factor: 4.575

2.  HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.

Authors:  Panpan An; Feng Chen; Zihan Li; Yuyi Ling; Yanxi Peng; Haisheng Zhang; Jiexin Li; Zhuojia Chen; Hongsheng Wang
Journal:  Oncogene       Date:  2020-06-04       Impact factor: 9.867

3.  Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer.

Authors:  Ting Ni; Xiao-Yan Li; Na Lu; Teng An; Zhi-Ping Liu; Rong Fu; Wen-Cong Lv; Yi-Wei Zhang; Xiao-Jun Xu; R Grant Rowe; Yong-Shun Lin; Amanda Scherer; Tamar Feinberg; Xiao-Qi Zheng; Bao-An Chen; X Shirley Liu; Qing-Long Guo; Zhao-Qiu Wu; Stephen J Weiss
Journal:  Nat Cell Biol       Date:  2016-10-17       Impact factor: 28.824

Review 4.  One microenvironment does not fit all: heterogeneity beyond cancer cells.

Authors:  Ik Sun Kim; Xiang H-F Zhang
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

5.  Inactivation of endothelial ZEB1 impedes tumor progression and sensitizes tumors to conventional therapies.

Authors:  Rong Fu; Yi Li; Nan Jiang; Bo-Xue Ren; Chen-Zi Zang; Li-Juan Liu; Wen-Cong Lv; Hong-Mei Li; Stephen Weiss; Zheng-Yu Li; Tao Lu; Zhao-Qiu Wu
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

6.  Inhibition of KPNA4 attenuates prostate cancer metastasis.

Authors:  J Yang; C Lu; J Wei; Y Guo; W Liu; L Luo; G Fisch; X Li
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

Review 7.  The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Authors:  Teizo Yoshimura
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

8.  Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.

Authors:  W-H Yang; Y-H Su; W-H Hsu; C-C Wang; J L Arbiser; M-H Yang
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

9.  Differential effects of Pax3 on expression of polysialyltransferases STX and PST in TGF-β-treated normal murine mammary gland cells.

Authors:  Dong Guo; Jia Guo; Xiang Li; Feng Guan
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 10.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.